Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
- Status
- TERMINATED
- Phase
- PHASE4
Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
- Status
- TERMINATED
- Phase
- PHASE3
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)
- Status
- COMPLETED
- Phase
- PHASE2